# reload+after+2024-01-20 07:47:50.871556
address1§44 Milton Avenue
city§Alpharetta
state§GA
zip§30009
country§United States
phone§866 620 8655
website§https://www.virios.com
industry§Biotechnology
sector§Healthcare
longBusinessSummary§Virios Therapeutics, Inc., a development-stage biotechnology company, focuses on developing novel antiviral therapies to treat diseases associated with a viral triggered abnormal immune response. The company's lead development candidate is the IMC-1, a fixed dose combination of famciclovir and celecoxib to treat fibromyalgia. It also develops IMC-2, a combination of valacyclovir and celecoxib for the treatment of managing the fatigue, sleep, attention, pain, autonomic function, and anxiety associated with long COVID. The company was formerly known as Innovative Med Concepts, LLC and changed its name to Virios Therapeutics, Inc. in July 2020. Virios Therapeutics, Inc. was founded in 2012 and is headquartered in Alpharetta, Georgia.
fullTimeEmployees§4
companyOfficers§[{'maxAge': 1, 'name': 'Mr. Gregory  Duncan', 'age': 58, 'title': 'Chairman & CEO', 'yearBorn': 1965, 'fiscalYear': 2022, 'totalPay': 559590, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Dr. William L. Pridgen M.D.', 'age': 62, 'title': 'Founder & Director', 'yearBorn': 1961, 'fiscalYear': 2022, 'totalPay': 35000, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Ms. Angela  Walsh', 'age': 56, 'title': 'CFO, SVP of Finance, Corporate Secretary & Treasurer', 'yearBorn': 1967, 'fiscalYear': 2022, 'totalPay': 281284, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Dr. R. Michael Gendreau M.D., Ph.D.', 'age': 67, 'title': 'Chief Medical Officer', 'yearBorn': 1956, 'fiscalYear': 2022, 'totalPay': 420644, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Mr. Ralph D. Grosswald M.P.H.', 'age': 54, 'title': 'Senior Vice President of Operations', 'yearBorn': 1969, 'fiscalYear': 2022, 'totalPay': 274693, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Ms. Carol  Duffy Ph.D.', 'title': 'Chief Scientific Advisor', 'fiscalYear': 2022, 'exercisedValue': 0, 'unexercisedValue': 0}]
compensationAsOfEpochDate§1672444800
maxAge§86400
priceHint§4
payoutRatio§0.0
beta§1.946
currency§USD
dateShortInterest§1702598400
forwardEps§-0.29
exchange§NCM
quoteType§EQUITY
shortName§Virios Therapeutics, Inc.
longName§Virios Therapeutics, Inc.
firstTradeDateEpochUtc§1608215400
timeZoneFullName§America/New_York
timeZoneShortName§EST
uuid§8121c959-cabe-3f8e-b316-31a94f2afcf2
gmtOffSetMilliseconds§-18000000
targetHighPrice§3.5
targetLowPrice§3.5
targetMeanPrice§3.5
targetMedianPrice§3.5
recommendationMean§3.0
recommendationKey§hold
numberOfAnalystOpinions§1
quickRatio§9.825
grossMargins§0.0
ebitdaMargins§0.0
trailingPegRatio§None
